Compatibility of turkey herpesvirus-infectious bursal disease vector vaccine with MAREK's disease rispens vaccine injected into day-old pullets

Avian Diseases

Volumn 55, Issue 1, 2011, Pages 113-118

  Lemiere, Stephane ^a   Wong, Siam Yit ^a   Saint Gerand, Anne Lise ^a   Goutebroze, Sylvain ^a   Le Gros, François Xavier ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

HVT + IBD vector vaccine; IBD serology; infectious bursal disease; Marek's disease; protection; Rispens vaccine

Indexed keywords

MAREK DISEASE VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIRD DISEASE; BIRNAVIRUS INFECTION; CHICKEN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GERMFREE ANIMAL; IMMUNOLOGY; INFECTIOUS BURSAL DISEASE VIRUS; MARDIVIRUS; MAREK DISEASE;

ANIMALS; BIRNAVIRIDAE INFECTIONS; CHICKENS; FEMALE; HERPESVIRUS 1, MELEAGRID; INFECTIOUS BURSAL DISEASE VIRUS; MAREK DISEASE; MAREK DISEASE VACCINES; POULTRY DISEASES; SPECIFIC PATHOGEN-FREE ORGANISMS;

MELEAGRID HERPESVIRUS 1; SPONDIAS PURPUREA;

EID: 79952941788     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/9507-081810-ResNote.1     Document Type: Article

References (24)

1. Bublot, M., N. Pritchard, F. X. Le Gros, and S. Goutebroze. Use of a vectored vaccine against infectious bursal disease of chickens in the face of high-titred maternally derived antibody. J. Comp. Pathol. 137:81-84. 2007.
2. Buscaglia, C., C. Nervi, and M. Risso. Characterization of four very virulent Argentinean strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses. Avian Pathol. 33:190-195. 2004. (Pubitemid 38517174)
3. Code of Federal Regulations, 9 C. F. R. 1 113.330. Marek's Disease vaccines. [Internet]. 1996. [cited 2011 January 3] Available at: http://law. justia.com/us/cfr/title09/9-1.0.1.5.0.74.113.html.
4. Darteil, R., M. Bublot, E. Laplace, J. F. Bouquet, J. C. Audonnet, and M. Riviere. Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens. Virology 211:481-490. 1995.
5. European Pharmacopeia, 6th ed. 2010 (6.8), 01/2008:058. Marek's Disease vaccine (live). [Internet]. 2008. [cited 2011 January 6] Available at: http://online6.edgm.eu/ep608/NetilsUtils/srvutil-getdoc.aspx/2L38nC35Sp DLmmDJWvHlveT6go/0589E.pdf.
6. Gimeno, I. M. Marek's disease vaccines: a solution for today but a worry for tomorrow? Vaccine 26 S: C31-C41. 2008. (Pubitemid 351899088)
7. Goutebroze, S., M. Curet, M. L. Jay, C. Roux, and F. X. Le Gros. Efficacy of a recombinant vaccine HVT-VP2 against Gumboro disease in the presence of maternal antibodies. Br. Poult. Sci. 44:824-825. 2003.
8. Kreager, K. S. Chicken industry strategies for control of tumor virus infections. Poult. Sci. 77:1213-1216. 1998. (Pubitemid 128527289)
9. Le Gros, F.-X., A. Dancer, C. Giacomini, L. Pizzoni, M. Bublot, M. Graziani, and F. Prandini. Field efficacy trial of a novel HVT-IBD vector vaccine for 1-day-old broilers. Vaccine 27:592-596. 2009.
10. Melchior, F. W., T. N. Frederickson, and R. E. Luginbuhl. Neutralization studies with Marek's disease virus and turkey herpesvirus. Appl. Microbiol. 26:925-933. 1976.
11. Morimura, T., K. Ohashi, C. Sugimoto, and M. Onuma. Pathogenesis of Marek's disease (MD) and possible mechanisms of immunity induced by MD vaccine. J. Vet. Med. Sci. 60:1-8. 1998. (Pubitemid 128534086)
12. Okazaki, W., H. G. Purchase, and B. R. Burmester. Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Dis. 14:423-429. 1970.
13. Rispens, B. H., H. van Vloten, N. Mastenbroek, J. L. Maas, and K. A. Schat. Control of Marek's disease in Netherlands. Part I. Isolation of an avirulent Marek's disease virus (strain CVI988) and its use in laboratory vaccination trials. Avian Dis. 16:108-125. 1972.
14. Rispens, B. H., H. van Vloten, N. Mastenbroek, J. L. Maas, and K. A. Schat. Control of Marek's disease in Netherlands. Part II. Field trials on vaccination with an avirulent strain (CVI988) of Marek's disease virus. Avian Dis. 16:126-138. 1972.
15. Schat, K. A., and B. W. Calnek. Protection against Marek's diseasederived tumor transplants by the nononcogenic SB-1 strain of Marek's disease virus. Infect. Immun. 22:225-232. 1978. (Pubitemid 9040722)
16. Tan, J., J. Cooke, N. Clarke, and G. A. Tannock. Molecular evaluation of responses to vaccination and challenge by Marek's disease viruses. Avian Pathol. 36:351-359. 2007. (Pubitemid 47509232)
17. Winterfield, R. W., F. J. Hoerr, and A. M. Fadly. Vaccination against infectious bronchitis and the immunosuppressive effects of infectious bursal disease. Poult. Sci. 57:386-391. 1978.
18. Winterfield, R. W., and H. L. Thacker. Immune response and pathogenicity of different strains of infectious bursal disease virus applied as vaccines. Avian Dis. 22:721-731. 1978.
19. Witter, R. L. Protection by attenuated and polyvalent vaccines against highly virulent strains of Marek's disease virus. Avian Pathol. 11:49-62. 1982.
20. Witter, R. L. Increased virulence of Marek's disease virus field isolates. Avian Dis. 41:149-153. 1987.
21. Witter, R. L. New serotype 2 and attenuated serotype 1 Marek's disease vaccine viruses: comparative efficacy. Avian Dis. 31:752-765. 1987.
22. Witter, R. L., and L. F. Lee. Polyvalent Marek's disease vaccines: safety, efficacy and protective synergism in chickens with maternal antibodies. Avian Pathol. 13:75-92. 1984.
23. Witter, R. L., K. Nazerian, H. G. Purchase, and G. H. Burgoyne. Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. Am. J. Vet. Res. 31:525-538. 1970.
24. Witter, R. L., J. M. Sharma, H. M. Opitz, and C. W. Henry. Field trials to test the efficacy of polyvalent Marek's disease vaccines in broilers. Avian Dis. 28:44-60. 1984.